AwardedSpainGoods€2,227,500
Suministro de medicamentos con principios activos Ustekinumab y Adalimumab 80 mg
- Published
- Published 27 November 2025
- Deadline
- Closed 9 January 2026
Overview
Suministro de medicamentos con principios activos Ustekinumab y Adalimumab 80 mg para los Centros dependientes del Servicio Murciano de Salud
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €2,227,500
- Procedure
- Open
- Published
- 27 November 2025
- Deadline
- Closed
Immunosuppressive agents
Award outcome
- Awarded value
- €2,901,898
- Award date
- 23 March 2026
- Contract period
- — → 18 March 2027
- BIOCON BIOLOGICS SPAIN, S.L.
- FRESENIUS KABI ESPAÑA, S.A.
- JANSSEN CILAG, S.A.
- SANDOZ FARMACEUTICA S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
5 May 2026
Contract Notice
27 November 2025
Contracting authority
Servicio Murciano de Salud - Junta de Compras
Procuring entityEspinardo, Spain
ID_PLATAFORMA: 41261690169929
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.